| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |